Abstract:Valeriana officinalis L. is a widely spread representative of the Eurasian flora. Preparations based on valerian extracts are recognized as sedatives, antidepressants and anxiolytics by both traditional and modern medicine. Despite the extremely high interest in the biological and pharmacological properties of valerian extracts, the composition of biologically active substances and specific activities of their components are still not completely studied. Therefore, here we address the metabolic profiles of the valerian plants with a special emphasis on their major root constituents with pronounced neuroprotective activity. The following phytochemical analysis of the V. officinalis L. roots led to isolation of nine compounds, including two previously undescribed iridoids – isovaltrate isovaleroyloxyisohydrin (1) and isovaltrate α-(isovaleroxy)isovaleroxyhydrin (2) together with one previously undescribed valerenic acid derivative – 2-oxovalerenic acid (3). Three previously described iridoids – iridoidvol A (4), isovaltrate isovaleroyloxyhydrin (5) and valtrate hydrine B1 (6), along with valerenic acid (7) and its metabolites - hydroxyvalerenic (8) and acetoxyvalerenic acids (9) were isolated. Functional assays accomplished with the isolated compounds revealed moderate antioxidant activity characteristic for all of them. Moreover, high neuroprotective potential was observed for the compound 3 (and to less extent of 8). This potential was manifested by a pronounced antineurodegenerative effect in the model of Aβ25-35 induced cytotoxicity. In respect of thrombin-induced platelet aggregation, compounds 1, 4 and 7 demonstrated pronounced inducing and compounds 2, 5 and 6 showed clear potentiating activity. Valerenic acid showed activity on TRPV1 ion channels, manifested by both channel activation and potentiation of the capsaicin response in CHO cells expressing TRPV1. Moderate antioxidant activity was characteristic of all compounds.

Jatavaleridoids A-H, eight new iridoids from the roots and rhizomes of Valeriana jatamansi Jones

Two New Iridoid Esters from the Root and Rhizome of Valeriana Jatamansi Jones

New Iridoids and Acyclic Monoterpenoids from the Roots and Rhizomes of Valeriana officinalis var. latifolia

Eighteen iridoids from the roots and rhizomes of Valeriana jatamansi and their protective effects against α-hemolysin

Iridoids from Valeriana jatamansi with anti-inflammatory and antiproliferative properties

Iridoids and other constituents from the leaves and stems of Valeriana officinalis var. latifolia

Iridoids and sesquiterpenoids from Valeriana jatamansi and their anti-influenza virus activities

Terpenoids from Tripterygium Wilfordii

Anti-Inflammatory Terpenoids From The Leaves And Twigs Of Dysoxylum Gotadhora

Iridoids and sesquiterpenoids from Valeriana officinalis and their bioactivities

Sesquiterpenoids and monoterpenoids from the water decoction of Valeriana officinalis L

Seventeen undescribed iridoid derivatives with anti-inflammatory effects from Hedyotis diffusa and their structure-activity relationships

Iridoid Glucosides from the Leaves of Vitex Negundo Var. Cannabifolia

Sesquiterpenoids from the roots and rhizomes of Valeriana officinalis var. latifolia

Analysis of Potential Antidiarrheal Metabolites in Fibrous Root, Rhizome, and Basal Leaf Samples from Valeriana Jatamansi

New Iridoids Possessing A Dioxatricyclodecane Skeleton from the Leaves of Viburnum Formosanum Hayata Subsp Leiogynum Hsu

Valerenic acid and iridoid derivatives from the roots of Valeriana officinalis L.

Cephaliverins A-D, four new lignans from Cephalotaxus oliveri Mast

Pentacyclic Triterpenoids from the Roots of Rhodomyrtus Tomentosa

Six new diterpenoids with anti-inflammatory and cytotoxic activity from Isodon serra

Five new secondary metabolites from Aster tataricus